QlearQuil Leverages Brand Into Allergy Space, Absorbs Existing ‘Quil’ Sinus Products
This article was originally published in The Tan Sheet
Executive Summary
P&G enters the OTC allergy category with QlearQuil products “for the occasional allergy sufferer.” But the firm also could be on the spot to prevent consumer confusion about indications for products in the broad selection with “Quil” in their brands.
You may also be interested in...
With PureZzzs, P&G Stretches ZzzQuil OTC Sleep Brand Into Supplement Space
P&G will launch Vicks ZzzQuil PureZzzs in late February as a drug-free, melatonin-based sleep aid, CFO Jon Moeller says. P&G hopes to reach $4.5bn in e-commerce sales in 2018, up from $3bn in 2017.
P&G Stretches ZzzQuil Sleep Brand Into Supplement Space With PureZzzs
P&G will launch Vicks ZzzQuil PureZzzs in late February as a drug-free, melatonin-based sleep aid, CFO Jon Moeller says. P&G hopes to reach $4.5bn in e-commerce sales in 2018, up from $3bn in 2017.
P&G Stretches ZzzQuil Sleep Brand Into Supplement Space With PureZzzs
P&G will launch Vicks ZzzQuil PureZzzs in late February as a drug-free, melatonin-based sleep aid, CFO Jon Moeller says. P&G hopes to reach $4.5bn in e-commerce sales in 2018, up from $3bn in 2017.